D
12.29
-1.31 (-9.60%)
| 前收盘价格 | 13.60 |
| 收盘价格 | 13.59 |
| 成交量 | 2,888,124 |
| 平均成交量 (3个月) | 1,123,258 |
| 市值 | 1,784,692,480 |
| 价格/销量 (P/S) | 3.64 |
| 股市价格/股市净资产 (P/B) | 1.83 |
| 52周波幅 | |
| 利润日期 | 5 May 2025 - 9 May 2025 |
| 稀释每股收益 (EPS TTM) | -2.57 |
| 总债务/股东权益 (D/E MRQ) | 4.42% |
| 流动比率 (MRQ) | 8.46 |
| 营业现金流 (OCF TTM) | -347.69 M |
| 杠杆自由现金流 (LFCF TTM) | -208.83 M |
| 资产报酬率 (ROA TTM) | -24.82% |
| 股东权益报酬率 (ROE TTM) | -37.40% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | Denali Therapeutics Inc. | 看跌 | 看跌 |
AIStockmoo 评分
2.3
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 0.5 |
| 平均 | 2.25 |
|
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 9.56% |
| 机构持股比例 | 90.82% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Crestline Management, Lp | 31 Dec 2024 | 4,310,732 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 42.00 (Oppenheimer, 241.74%) | 购买 |
| 中 | 31.50 (156.31%) | |
| 低 | 28.00 (B of A Securities, 127.83%) | 购买 |
| 平均值 | 32.50 (164.44%) | |
| 总计 | 8 购买 | |
| 平均价格@调整类型 | 10.47 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Baird | 08 May 2025 | 29.00 (135.96%) | 购买 | 0.000 |
| HC Wainwright & Co. | 07 May 2025 | 32.00 (160.37%) | 购买 | 0.000 |
| 28 Feb 2025 | 87.00 (607.89%) | 购买 | 16.56 | |
| Wedbush | 07 May 2025 | 30.00 (144.10%) | 购买 | 0.000 |
| B of A Securities | 10 Mar 2025 | 28.00 (127.83%) | 购买 | 14.95 |
| Morgan Stanley | 07 Mar 2025 | 33.00 (168.51%) | 购买 | 16.69 |
| B. Riley Securities | 05 Mar 2025 | 35.00 (184.78%) | 购买 | 16.30 |
| Oppenheimer | 03 Mar 2025 | 42.00 (241.74%) | 购买 | 15.20 |
| Deutsche Bank | 11 Feb 2025 | 31.00 (152.24%) | 购买 | 20.58 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合